Trial intelligence / Profile preview

DSM265 for malaria prophylaxis in healthy volunteers

NCT02450578Phase 1Completed

Sponsor
Medicines for Malaria Venture
Start
Oct 2015
Primary completion
Apr 2016
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of DSM265 in malaria, sponsored by Medicines for Malaria Venture. Started Oct 2015; status: completed.

02

Drugs

DSM265
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02450578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02450578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call